Catalyst Wire Dossier Catalyst Wire Dossier

Telmisartan/hydrochlorothiazide (fixed-dose combination)

Telmisartan and hydrochlorothiazide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Telmisartan/hydrochlorothiazide (fixed-dose combination), covering 2013-11-13 to 2014-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers [Phase 1]

See pricing